Cargando…
Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization
Endocrine therapy is the standard treatment for estrogen receptor (ER)-positive breast cancer, but tumors eventually develop resistance. However, endocrine therapy resistance mechanisms mediated through interactions between breast cancer cells and tumor-associated macrophages (TAMs) are still unclea...
Autores principales: | Niu, Xingjian, Ma, Jianli, Li, Jingtong, Gu, Yucui, Yin, Lei, Wang, Yiran, Zhou, Xiaoping, Wang, Jinlu, Ji, Hongfei, Zhang, Qingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131586/ https://www.ncbi.nlm.nih.gov/pubmed/34006822 http://dx.doi.org/10.1038/s41419-021-03781-x |
Ejemplares similares
-
HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer
por: Zhang, Han, et al.
Publicado: (2021) -
Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
por: Li, Dongbo, et al.
Publicado: (2019) -
Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer
por: Wang, Jinlu, et al.
Publicado: (2020) -
Enhancing Fatty Acid Catabolism of Macrophages Within Aberrant Breast Cancer Tumor Microenvironment Can Re-establish Antitumor Function
por: Gu, Yucui, et al.
Publicado: (2021) -
Serum amyloid A 1 induces suppressive neutrophils through the Toll‐like receptor 2–mediated signaling pathway to promote progression of breast cancer
por: Niu, Xingjian, et al.
Publicado: (2022)